About
Articular Cartilage Repair
CartiCure is an early-stage company dedicated to the development of cartilage repair products. CartiCure's technological platform generates original hyaline cartilage-producing cells to be transplanted into damaged joints, efficiently replenishing lesions in the articular cartilage. The company's first product, Cartimove, is designed for treatment of knee cartilage damage that results from trauma injuries. The company's next-generation product is targeted at the osteoarthritis market. The company is supported by the NGT High-Tech Incubator in Nazareth, Israel. Scientific work and ongoing animal trials are being conducted at the Faculty of Medicine at the Technion-Institute of Technology in Haifa, Israel. The company has successfully completed pre-clinical studies performed in large and small animals. It has a strong IP portfolio thatincludes a granted US patent.
Identity
| Name | CartiCure |
|---|---|
| Slug | carticure |
| Type / kind | startup |
| Crunchbase ID | carticure |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6Yo40LDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Aug 2017 |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Nof HaGalil |
| HQ address | Nazareth Illit, Israel |
Classifications
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}